{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:30:31Z","timestamp":1787509831736,"version":"build-2736575974"},"reference-count":23,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"DOI":"10.1001\/jamadermatol.2022.2721","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T11:05:57Z","timestamp":1657710357000},"source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and Safety of Topical Nitric Oxide\u2212Releasing Berdazimer Gel in Patients With Molluscum Contagiosum"],"prefix":"10.1001","author":[{"given":"John C.","family":"Browning","sequence":"first","affiliation":[{"name":"Texas Dermatology and Laser Specialists, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Enloe","sequence":"additional","affiliation":[{"name":"Novan Inc, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Cartwright","sequence":"additional","affiliation":[{"name":"Novan Inc, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Hebert","sequence":"additional","affiliation":[{"name":"University of Texas Health McGovern Medical School, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[{"name":"The Feinberg School of Medicine of Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hebert","sequence":"additional","affiliation":[{"name":"Novan Inc, Durham, North Carolina"},{"name":"Radius Health Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Kearney","family":"Kowalewski","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Maeda-Chubachi","sequence":"additional","affiliation":[{"name":"Novan Inc, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"10","key":"doi220032r1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1473-3099(13)70109-9","article-title":"Molluscum contagiosum virus infection.","volume":"13","author":"Chen","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"doi220032r2","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/bjd.2011.165.issue-5","article-title":"Skin conditions are the commonest new reason people present to general practitioners in England and Wales.","volume":"165","author":"Schofield","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi220032r3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jaad.2005.08.035","article-title":"The epidemiology of molluscum contagiosum in children.","volume":"54","author":"Dohil","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"doi220032r4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.aivir.2014.11.004","article-title":"Immune evasion strategies of molluscum contagiosum virus.","volume":"92","author":"Shisler","year":"2015","journal-title":"Adv Virus Res"},{"issue":"5","key":"doi220032r5","doi-asserted-by":"publisher","first-page":"e1650","DOI":"10.1542\/peds.2012-2933","article-title":"Molluscum BOTE sign: a predictor of imminent resolution.","volume":"131","author":"Butala","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"doi220032r6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1473-3099(14)71053-9","article-title":"Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study.","volume":"15","author":"Olsen","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"doi220032r7","article-title":"Interventions for cutaneous molluscum contagiosum.","volume":"5","author":"van der Wouden","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"doi220032r8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ad.2018.01.007","article-title":"Update on the treatment of molluscum contagiosum in children.","volume":"109","author":"Gerlero","year":"2018","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"642","key":"doi220032r9","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.3399\/bjgp15X688093","article-title":"Molluscum contagiosum and associations with atopic eczema in children: a retrospective longitudinal study in primary care.","volume":"66","author":"Olsen","year":"2016","journal-title":"Br J Gen Pract"},{"issue":"1","key":"doi220032r10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1872213X11666170518114456","article-title":"Molluscum contagiosum: an update.","volume":"11","author":"Leung","year":"2017","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"issue":"12","key":"doi220032r11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jamadermatol.2020.3238","article-title":"Safety and efficacy of VP-102, a proprietary, drug-device combination product containing cantharidin, 0.7% (w\/v), in children and adults with molluscum contagiosum: two phase 3 randomized clinical trials.","volume":"156","author":"Eichenfield","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"doi220032r12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1473-3099(14)70728-5","article-title":"Imiquimod is not an effective drug for molluscum contagiosum.","volume":"14","author":"Katz","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"doi220032r13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/jamadermatol.2014.3335","article-title":"Dermatologists, imiquimod, and treatment of molluscum contagiosum in children: righting wrongs.","volume":"151","author":"Katz","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi220032r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2013-0116","article-title":"Imiquimod, molluscum, and the need for a better \u201cBest Pharmaceuticals for Children\u201d Act.","volume":"132","author":"Katz","year":"2013","journal-title":"Pediatrics"},{"issue":"10","key":"doi220032r15","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1111\/jde.2018.45.issue-10","article-title":"Efficacy of combination therapies of topical 5% imiquimod and liquid nitrogen for penile molluscum contagiosum.","volume":"45","author":"Go","year":"2018","journal-title":"J Dermatol"},{"issue":"7","key":"doi220032r16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01026-17","article-title":"Nitric oxide-releasing macromolecule exhibits broad-spectrum antifungal activity and utility as a topical treatment for superficial fungal infections.","volume":"62","author":"Stasko","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"doi220032r17","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1093\/nar\/24.12.2236","article-title":"Inhibition of NF-kappaB DNA binding by nitric oxide.","volume":"24","author":"Matthews","year":"1996","journal-title":"Nucleic Acids Res"},{"key":"doi220032r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104559","article-title":"NVN1000, a novel nitric oxide-releasing compound, inhibits HPV-18 virus production by interfering with E6 and E7 oncoprotein functions.","volume":"170","author":"Banerjee","year":"2019","journal-title":"Antiviral Res"},{"issue":"10","key":"doi220032r19","first-page":"1100","article-title":"A phase 2 controlled study of SB206, a topical nitric oxide-releasing drug for extragenital wart treatment.","volume":"17","author":"Tyring","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"doi220032r20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.jaad.2019.09.064","article-title":"Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: a randomized clinical trial.","volume":"82","author":"Hebert","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi220032r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100019","article-title":"SB206, a nitric oxide-releasing topical medication, induces the beginning of the end sign and molluscum clearance.","volume":"1","author":"Maeda-Chubachi","year":"2021","journal-title":"JID Innov"},{"key":"doi220032r22","author":"Hebert","year":"2018"},{"key":"doi220032r23","author":"McHale","year":"2016"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2794188\/jamadermatology_browning_2022_oi_220032_1657244654.3167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T11:06:04Z","timestamp":1657710364000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2794188"}},"subtitle":["A Phase 3 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.2721","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}